Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response

JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathway

(2023) Yaru Lu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Butyrate Properties in Immune-Related Diseases: Friend or Foe?

(2023) Muhammad Anshory et al.   Fermentation-Basel

A Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in Mice

(2022) Liqiong Song et al.   Frontiers in Immunology

The gut microbiome and mental health: advances in research and emerging priorities

(2022) Andrew P. Shoubridge et al.   MOLECULAR PSYCHIATRY

Dynamic metabolic interactions and trophic roles of human gut microbes identified using a minimal microbiome exhibiting ecological properties

(2022) Sudarshan A. Shetty et al.   ISME Journal

Gut microbiota and metabolites in myasthenia gravis: Early diagnostic biomarkers and therapeutic strategies

(2022) Yongbo Kang et al.   CLINICAL IMMUNOLOGY

Butyrate Shapes Immune Cell Fate and Function in Allergic Asthma

(2021) William Yip et al.   Frontiers in Immunology

Imbalance of Th17 and Tregs in thymoma may be a pathological mechanism of myasthenia gravis

(2021) Yuan Chen et al.   MOLECULAR IMMUNOLOGY

Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3

(2021) Francesco Beghini et al.   eLife

Metagenome-wide association study of gut microbiome revealed potential microbial marker set for diagnosis of pediatric myasthenia gravis

(2021) Peng Liu et al.   BMC Medicine

Mitochondrial Dynamics and Mitophagy in Skeletal Muscle Health and Aging

(2021) Jean-Philippe Leduc-Gaudet et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

NF-κB: At the Borders of Autoimmunity and Inflammation

(2021) Laura Barnabei et al.   Frontiers in Immunology

Gut Microbiota as Regulators of Th17/Treg Balance in Patients With Myasthenia Gravis

(2021) Pan Chen et al.   Frontiers in Immunology

Stigmasterol Restores the Balance of Treg/Th17 Cells by Activating the Butyrate-PPARγ Axis in Colitis

(2021) Shuting Wen et al.   Frontiers in Immunology

The Immunomodulatory Functions of Butyrate

(2021) Mohamed Tausif Siddiqui et al.   Journal of Inflammation Research

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics

(2020) Konstantinos Lazaridis et al.   Frontiers in Immunology

New Approaches to Targeting B Cells for Myasthenia Gravis Therapy

(2020) Ruksana Huda   Frontiers in Immunology

Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth

(2020) Elena Zagato et al.   Nature Microbiology

CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS

(2020) Merve Çebi et al.   Frontiers in Immunology

Effects of Mitophagy on Regulatory T Cell Function in Patients With Myasthenia Gravis

(2020) Na Wang et al.   Frontiers in Neurology

The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health

(2020) Bianca J. Parker et al.   Frontiers in Immunology

Roles of cytokines and T cells in the pathogenesis of myasthenia gravis

(2020) A. Uzawa et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

The neuroactive potential of the human gut microbiota in quality of life and depression

(2019) Mireia Valles-Colomer et al.   Nature Microbiology

Defining the role of Parasutterella, a previously uncharacterized member of the core gut microbiota

(2019) Tingting Ju et al.   ISME Journal

Mucispirillum schaedleri Antagonizes Salmonella Virulence to Protect Mice against Colitis

(2019) Simone Herp et al.   Cell Host & Microbe

The pathogenicity of Th17 cells in autoimmune diseases

(2019) Keiko Yasuda et al.   Seminars in Immunopathology

Inhibition of ROCK activity regulates the balance of Th1, Th17 and Treg cells in myasthenia gravis

(2019) Jie Song et al.   CLINICAL IMMUNOLOGY

Gut commensalParabacteroides goldsteiniiplays a predominant role in the anti-obesity effects of polysaccharides isolated fromHirsutella sinensis

(2018) Tsung-Ru Wu et al.   GUT

Altered Gut Microbiota in Myasthenia Gravis

(2018) Dongxu Qiu et al.   Frontiers in Microbiology

Butyrate Producers as Potential Next-Generation Probiotics: Safety Assessment of the Administration of Butyricicoccus pullicaecorum to Healthy Volunteers

(2018) Leen Boesmans et al.   mSystems

A sensitive GC/MS detection method for analyzing microbial metabolites short chain fatty acids in fecal and serum samples

(2018) Shuming Zhang et al.   TALANTA

Regulatory T cells in multiple sclerosis and myasthenia gravis

(2017) K. M. Danikowski et al.   Journal of Neuroinflammation

The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases

(2017) Taku Kuwabara et al.   MEDIATORS OF INFLAMMATION

B cells in the pathophysiology of myasthenia gravis

(2017) John S. Yi et al.   MUSCLE & NERVE

High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients

(2017) Yongxiang Yang et al.   NEUROLOGICAL SCIENCES

Genomic and functional analysis of Romboutsia ilealis CRIBT reveals adaptation to the small intestine

(2017) Jacoline Gerritsen et al.   PeerJ

Assessment of the cPAS-based BGISEQ-500 platform for metagenomic sequencing

(2017) Chao Fang et al.   GigaScience

Fiber-utilizing capacity varies in Prevotella- versus Bacteroides-dominated gut microbiota

(2017) Tingting Chen et al.   Scientific Reports

T follicular helper cells in human autoimmunity

(2016) Hideki Ueno   CURRENT OPINION IN IMMUNOLOGY

Augmentation of Circulating Follicular Helper T Cells and Their Impact on Autoreactive B Cells in Myasthenia Gravis

(2016) Cun-Jin Zhang et al.   JOURNAL OF IMMUNOLOGY

Randomized Trial of Thymectomy in Myasthenia Gravis

(2016) Gil I. Wolfe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin

(2016) Elena Cortés-Vicente et al.   JAMA Neurology

Species–function relationships shape ecological properties of the human gut microbiome

(2016) Sara Vieira-Silva et al.   Nature Microbiology

IL-17-producing CD4+T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis

(2015) Hanne Schaffert et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Telephone-Delivered Cognitive Behavioral Therapy and Telephone-Delivered Nondirective Supportive Therapy for Rural Older Adults With Generalized Anxiety Disorder

(2015) Gretchen A. Brenes et al.   JAMA Psychiatry

Silencing miR-146a influences B cells and ameliorates experimental autoimmune myasthenia gravis

(2014) JunMei Zhang et al.   IMMUNOLOGY

Role of PI3K/Akt and mTOR complexes in Th17 cell differentiation

(2013) Shigenori Nagai et al.   Annals of the New York Academy of Sciences

Genetic basis of myasthenia gravis – A comprehensive review

(2013) Nili Avidan et al.   JOURNAL OF AUTOIMMUNITY

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions

(2013) Daehwan Kim et al.   GENOME BIOLOGY

Lactobacillus pasteurii sp. nov. and Lactobacillus hominis sp. nov.

(2012) S. Cousin et al.   INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY

Complement regulatory protein Crry deficiency contributes to the antigen specific recall response in experimental autoimmune myasthenia gravis

(2012) Jindrich Soltys et al.   Journal of Inflammation-London

A metagenome-wide association study of gut microbiota in type 2 diabetes

(2012) Junjie Qin et al.   NATURE

Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets

(2011) R. D. Michalek et al.   JOURNAL OF IMMUNOLOGY

Increased serum interleukin-17 levels in patients with myasthenia gravis

(2011) Jose C. Roche et al.   MUSCLE & NERVE

Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients

(2010) Masayuki Masuda et al.   JOURNAL OF NEUROIMMUNOLOGY

Biotransformation of Daidzein to Equol by Crude Enzyme fromAsaccharobacter celatusAHU1763 Required an Anaerobic Environment

(2009) Charin THAWORNKUNO et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Selective Targeting of B Cells with Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/lpr Mice

(2009) P. A. Blair et al.   JOURNAL OF IMMUNOLOGY

CD4+T Cells and Cytokines in the Pathogenesis of Acquired Myasthenia Gravis

(2008) Bianca M. Conti-Fine et al.   Annals of the New York Academy of Sciences

Asaccharobacter celatus gen. nov., sp. nov., isolated from rat caecum

(2008) K. Minamida et al.   INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY

Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella

(2008) T. Maruo et al.   INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY

Decrease of CD4+CD25highFoxp3+ regulatory T cells and elevation of CD19+BAFF-R+ B cells and soluble ICAM-1 in myasthenia gravis

(2007) Xiang Li et al.   CLINICAL IMMUNOLOGY